Literature DB >> 130383

Ischemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding.

G A Beller, J Conroy, T W Smith.   

Abstract

The effects of ischemia on the canine myocardial (Na+ + K+)-ATPase complex were examined in terms of alterations in cardiac glycoside binding and enzymatic activity. Ability of the myocardial cell to bind tritiated ouabain in vivo was assessed after 1, 2, and 6 h of coronary occlusion followed by 45 min of reperfusion, and correlated with measurements of in vitro (Na+ + K+)-ATPase activity and in vitro [3H]ouabain binding after similar periods of ischemia. Regional blood flow alterations during occlusion and reperfusion were simultaneously determined utilizing 15 mum radioactive microspheres to determine the degree to which altered binding of ouabain might be flow related. Anterior wall infarction was produced in 34 dogs by snaring of confluent branches of the left coronary system. Epicardial electrograms delineated ischemic and border zone areas. Coronary reperfusion after 2 and 6 h of occlusion was associated with impaired reflow of blood and markedly impaired uptake of [3H]ouabain in ischemic myocardium. In both groups, in vivo [3H]ouabain binding by ischemic tissue was reduced out of proportion to the reduction in flow. Despite near-complete restoration of flow in seven dogs occluded for 1 h and reperfused, [3H]ouabain remained significantly reduced to 58 +/- 9% of nonischemic uptake in subendocardial layers of the central zone of ischemia. Thus, when coronary flow was restored to areas of myocardium rendered acutely ischemia for 1 or more hours, ischemic zones demonstrated progressively diminished ability to bind ouabain. To determine whether ischemia-induced alteration in myocardial (Na+ + K+)-ATPase might underlie these changes, (Na+ + K+)-ATPase activity and [3H]ouabain binding were measured in microsomal fractions from ischemic myocardium after 1, 2, and 6 h of coronary occlusion. In animals occluded for 6 h, (Na+ + K+)-ATPase activity was significantly reduced by 40% in epicardial and by 35% in endocardial layers compared with nonischemic myocardium. Comparable reductions in in vitro [3H]ouabain binding were also demonstrated. Reperfusion for 45 min after occlusion for 6 h resulted in no significant restoration of enzyme activity when compared to the nonreperfused animals. In six animals occluded for 2 h, a time at which myocardial creatine phosphokinase activity remains unchanged, (Na+ + K+)-ATPase activity was reduced by 25% compared with nonischemic enzyme activity. In five dogs occluded for 1 h, (Na+ + K+)-ATPase activity in ischemic myocardium was unchanged from control levels. We conclude that reduced regional myocardial blood flow, local alterations in cellular milieu, and altered glycoside-binding properties of (Na+ + K+)-ATPase all participate in the reduction of cardiac glycoside binding observed after reperfusion of ischemic myocardium. In addition, after 2 or more hours of severe ischemia, myocardial (Na+ + K+)-ATPase catalytic activity is significantly reduced despite incubation in the presence of optimal substrate concentrations.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 130383      PMCID: PMC436658          DOI: 10.1172/JCI108285

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

Review 1.  Digitalis (third of four parts).

Authors:  T W Smith; E Haber
Journal:  N Engl J Med       Date:  1973-11-15       Impact factor: 91.245

Review 2.  Effects of digitalis on myocardial ionic exchange.

Authors:  G A Langer
Journal:  Circulation       Date:  1972-07       Impact factor: 29.690

3.  Biochemical and morphologic correlates of cardiac ischemia. I. Membrane systems.

Authors:  A Schwartz; J M Wood; J C Allen; E P Bornet; M L Entman; M A Goldstein; L A Sordahl; M Suzuki
Journal:  Am J Cardiol       Date:  1973-07       Impact factor: 2.778

4.  Biochemical basis of heart function. X. Reduction in the Na+-K+-stimulated ATPase activity in failing rat heart due to hypoxia.

Authors:  V Balasubramanian; D B McNamara; J N Singh; N S Dhalla
Journal:  Can J Physiol Pharmacol       Date:  1973-07       Impact factor: 2.273

Review 5.  The subcellular basis for the mechanism of inotropic action of cardiac glycosides.

Authors:  K S Lee; W Klaus
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

6.  The effect of ouabain on sodium- and potassium-activated adenosine triphosphatase from the hearts of several mammalian species.

Authors:  T Akera; F S Larsen; T M Brody
Journal:  J Pharmacol Exp Ther       Date:  1969-11       Impact factor: 4.030

7.  Correlation of cardiac sodium- and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation.

Authors:  T Akera; F S Larsen; T M Brody
Journal:  J Pharmacol Exp Ther       Date:  1970-05       Impact factor: 4.030

8.  Correlation between the inotropic action of ouabain and its effects on subcellular enzyme systems from canine myocardium.

Authors:  H R Besch; J C Allen; G Glick; A Schwartz
Journal:  J Pharmacol Exp Ther       Date:  1970-01       Impact factor: 4.030

9.  Digoxin distribution in the dog's left ventricle in the presence of coronary artery ligation.

Authors:  B E Hopkins; R R Taylor; C Henderson; P Burrows
Journal:  J Mol Cell Cardiol       Date:  1973-04       Impact factor: 5.000

10.  Effect of a pharmacologic dose of digoxin on inotropy in hyper- and normokalemic dogs.

Authors:  R H Goldman; R N Deutscher; E Schweizer; D C Harrison
Journal:  Am J Physiol       Date:  1972-12
View more
  22 in total

1.  Deleterious effects of digitalis on reperfusion-induced arrhythmias and myocardial injury in ischemic rat hearts: possible involvements of myocardial Na+ and Ca2+ imbalance.

Authors:  M Tani; J R Neely
Journal:  Basic Res Cardiol       Date:  1991 Jul-Aug       Impact factor: 17.165

2.  Quantification of the total Na,K-ATPase concentration in atria and ventricles from mammalian species by measuring 3H-ouabain binding to intact myocardial samples. Stability to short term ischemia reperfusion.

Authors:  T A Schmidt; J H Svendsen; S Haunsø; K Kjeldsen
Journal:  Basic Res Cardiol       Date:  1990 Jul-Aug       Impact factor: 17.165

3.  Alterations in cardiac function and subcellular membrane activities after hypervitaminosis D3.

Authors:  S Takeo; R Tanonaka; K Tanonaka; K Miyake; H Hisayama; N Ueda; K Kawakami; H Tsumura; S Katsushika; Y Taniguchi
Journal:  Mol Cell Biochem       Date:  1991-10-16       Impact factor: 3.396

4.  Alterations in cation homeostasis in cultured chick ventricular cells during and after recovery from adenosine triphosphate depletion.

Authors:  H Ishida; O Kohmoto; J H Bridge; W H Barry
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

Review 5.  Human myocardial Na,K-ATPase concentration in heart failure.

Authors:  H Bundgaard; K Kjeldsen
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

6.  Increased alpha-adrenergic receptors in ischemic cat myocardium. A potential mediator of electrophysiological derangements.

Authors:  P B Corr; J A Shayman; J B Kramer; R J Kipnis
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

Review 7.  Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia.

Authors:  J L Farber; K R Chien; S Mittnacht
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

8.  Characterisation of the canine cardiac sarcolemma in experimental myocardial ischemia.

Authors:  T J Netticadan; T F Ashavaid; K G Nair
Journal:  Indian J Clin Biochem       Date:  1997-12

9.  Abnormalities of volume regulation and membrane integrity in myocardial tissue slices after early ischemic injury in the dog: effects of mannitol, polyethylene glycol, and propranolol.

Authors:  L M Buja; J T Willerson
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

Review 10.  Control of cardiac contraction by sodium: Promises, reckonings, and new beginnings.

Authors:  Donald W Hilgemann
Journal:  Cell Calcium       Date:  2019-11-22       Impact factor: 6.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.